You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Patent: 10,040,859


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,040,859
Title:Methods of treating hemophagocytic lymphohistiocytosis with an IL-33 receptor antibody
Abstract: Compositions and methods for treating a cytokine release syndrome such as chimeric antigen receptor T-cell cytokine release syndrome or hemophagocytic lymphohistiocytosis are provided.
Inventor(s): Behrens; Edward M. (West Chester, PA), Rood; Julia E. (Philadelphia, PA), Kambayashi; Taku (Malvern, PA)
Assignee: The Children\'s Hospital of Philadelphia (Philadelphia, PA) The Trustees of the University of Pennsylvania (Philadelphia, PA)
Application Number:15/305,272
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis Using United States Patent 10,040,859 as an Example

Introduction

Patents are a crucial component of intellectual property law, providing inventors and innovators with exclusive rights to their inventions. In the United States, patents are governed by the Patent Act (35 U.S. Code) and administered by the United States Patent and Trademark Office (USPTO)[1].

Overview of U.S. Patent Types

Before diving into the specifics of a particular patent, it's essential to understand the types of patents that can be granted. The most common types include:

  • Utility Patents: These protect functional inventions and have a duration of 20 years from the date of filing.
  • Design Patents: These protect ornamental designs.
  • Plant Patents: These protect new varieties of asexually reproducing plants[1].

The Patent Application Process

To obtain a patent, an applicant must submit a patent application to the USPTO. This application includes several key components:

  • Title: A brief title of the invention.
  • Abstract: A concise summary of the invention.
  • Drawings: Illustrations of the invention.
  • Background of the Invention: A description of the prior art and the problem the invention solves.
  • Brief Summary of the Invention: A summary of the invention.
  • Description: A detailed description of the invention, including how it is made and used[4].

Claims in a Patent Application

Claims are the most critical part of a patent application as they define the scope of the invention and what is protected by the patent. Here are some key points about claims:

Types of Claims

  • Independent Claims: These claims stand alone and do not depend on other claims.
  • Dependent Claims: These claims depend on other claims and further limit the scope of the invention.
  • Multiple Dependent Claims: These claims depend on more than one other claim[2].

Claim Fees

In the U.S., claim fees are payable for:

  • Each claim in excess of 20 ($100 per claim).
  • Each independent claim in excess of 3 ($480 per claim).
  • The presence of a multiple dependent claim ($860)[2].

Analyzing the Scope of a Patent: United States Patent 10,040,859

To analyze the scope of a specific patent, such as United States Patent 10,040,859, one must carefully review the claims and the detailed description provided in the patent.

Reading the Claims

The claims section of the patent outlines what the inventor is seeking to protect. Here, you would identify:

  • Independent Claims: These define the broadest scope of the invention.
  • Dependent Claims: These narrow down the scope by adding additional limitations.

Understanding the Description

The description section provides detailed information about the invention, including its components, how it works, and any variations or embodiments. This section helps in understanding the context and scope of the claims.

Identifying Key Elements

Identify the key elements of the invention as described in the claims and the description. These elements are crucial in determining what is protected and what is not.

Patent Subject Matter Eligibility

When analyzing a patent, it is important to consider whether the invention falls within the statutory categories of subject matter eligibility under Section 101 of the Patent Act. This includes:

  • Four Statutory Categories: Processes, machines, manufactures, and compositions of matter.
  • Non-Statutory Exceptions: Abstract ideas, natural phenomena, and laws of nature.
  • The Alice Test: A two-step test to determine if an invention is an abstract idea and if it has an inventive concept[1].

Timeline and Costs for Patent Filings

The process of obtaining a patent can be lengthy and costly. Here are some key points:

  • Timeline: The time to first office action can vary significantly depending on the technology area, ranging from about 12 to 30 months[4].
  • Costs: Official fees vary based on the size of the application and the number of claims. Additional costs include attorney fees and other expenses associated with the application process[4].

Preserving Provisional Rights

For pre-issuance patent damages, it is crucial to understand the rules regarding provisional rights. This includes:

  • Publication of the Patent Application: Applications are published 18 months after filing.
  • Actual Notice Requirement: The infringing party must have actual knowledge of the published patent application to be liable for damages[5].

Key Takeaways

  • Claims Define the Scope: The claims section is the most critical part of a patent application.
  • Fees and Costs: Claim fees and other costs can be significant and should be managed carefully.
  • Subject Matter Eligibility: Ensure the invention falls within the statutory categories and passes the Alice test.
  • Timeline: Be prepared for a lengthy examination process.
  • Provisional Rights: Understand the requirements for pre-issuance patent damages.

FAQs

What are the different types of patents in the United States?

The main types of patents in the U.S. are utility patents, design patents, and plant patents. Utility patents protect functional inventions, design patents protect ornamental designs, and plant patents protect new varieties of asexually reproducing plants[1].

How do claim fees work in the U.S.?

In the U.S., claim fees are payable for each claim in excess of 20, each independent claim in excess of 3, and for the presence of a multiple dependent claim. The fees are $100 per claim for claims over 20, $480 per independent claim over 3, and $860 for a multiple dependent claim[2].

What is the Alice test in patent law?

The Alice test is a two-step test used to determine if an invention is an abstract idea and if it has an inventive concept. It involves analyzing whether the claim is directed to an abstract idea and whether the claim contains an inventive concept that transforms the abstract idea into a patentable invention[1].

How long does the patent examination process typically take?

The time to first office action and total pendency can vary significantly depending on the technology area, ranging from about 12 to 30 months. For example, computer architecture and software patents can take almost 21 months to receive the first office action, while mechanical engineering patents can take around 30 months to complete the process[4].

What is the actual notice requirement for pre-issuance patent damages?

For pre-issuance patent damages, the infringing party must have actual knowledge of the published patent application. Constructive notice is not sufficient; the infringing party must have been affirmatively notified of the published application[5].

Sources

  1. BitLaw: Patent Law in the United States.
  2. Plass: Claim fees: how to avoid their payment? - Obtaining an EP Patent.
  3. USPTO: Patent Claims Research Dataset.
  4. SBIR: TIMELINE AND COSTS FOR PATENT FILINGS.
  5. Kramer Levin: Preserving Provisional Rights for Pre-Issuance Patent Damages.

More… ↓

⤷  Subscribe

Details for Patent 10,040,859

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Kiniksa Pharmaceuticals (uk), Ltd. ARCALYST rilonacept For Injection 125249 February 27, 2008 10,040,859 2034-04-21
Novartis Pharmaceuticals Corporation ILARIS canakinumab For Injection 125319 June 17, 2009 10,040,859 2034-04-21
Novartis Pharmaceuticals Corporation ILARIS canakinumab Injection 125319 December 22, 2016 10,040,859 2034-04-21
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.